Valeant Pharmaceuticals reported CAD10.14B in Market Capitalization this March of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Amgen AMGN:US $ 129.08B 2.36B
Ani Pharmaceuticals ANIP:US $ 0.49B 0.29B
Aurora Cannabis Inc ACB:CN 1.12B 240.7M
Biogen BIIB:US $ 30.95B 4.29B
Bristol Myers Squibb BMY:US $ 155.49B 17.09B
Canopy Growth Corp WEED:CN C$ 3.74B 609.15M
Catalent CTLT:US $ 19.86B 2.05B
Corcept Therapeutics CORT:US $ 2.39B 0.1B
Danaher DHR:US $ 209.99B 25.11B
Drreddys Laboratories RDY:US 10.94B 0.02B
Eli Lilly And LLY:US $ 272.72B 8.49B
Endo International Ordinary Shares ENDP:US 0.54B 0.34B
Gilead Sciences GILD:US $ 74.66B 16.42B
Horizon Pharma HZNP:US 24.14B 0.3B
Lannett LCI:US $ 0.03B 0.04B
Nektar Therapeutics NKTR:US $ 2.49B 0.81B
Pacira Pharmaceuticals PCRX:US $ 3.42B 0.74B
Phibro Animal Health PAHC:US $ 0.81B 0.02B
Prestige Brands PBH:US $ 2.66B 0.38B
Supernus Pharmaceuticals SUPN:US $ 1.55B 0.13B
Valeant Pharmaceuticals VRX:CN C$ 10.14B 2.41B
Zoetis ZTS:US $ 88.87B 26.58B